Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
6.71
-0.02 (-0.30%)
Nov 17, 2026, 3:00 PM CST

SHA:603229 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
756.55792.26795.07814.85764.23568.89
Other Revenue
0.50.50.221.920.320.81
757.05792.76795.29816.77764.55569.7
Revenue Growth
0.79%-0.32%-2.63%6.83%34.20%39.21%
Cost of Revenue
413.2388.15373.39372.41372.58261.29
Gross Profit
343.86404.61421.9444.36391.96308.41
Selling, General & Admin
125.99117.98123.21118.41114.5581.25
Research & Development
204.62167.89100.4278.0667.0768.82
Other Operating Expenses
13.755.856.543.321.974.64
Operating Expenses
346.33287.41237.43199.81186.76156.21
Operating Income
-2.47117.21184.48244.54205.2152.2
Interest Expense
-9.72-8.09-7.76-7.99-6.11-1.47
Interest & Investment Income
42.846.1643.0835.759.65.78
Currency Exchange Gain (Loss)
-20.61-20.6111.411.3740.58-9.67
Other Non Operating Income (Expenses)
-40.26-0.29-0.27-0.6-0.44-0.44
EBT Excluding Unusual Items
-30.26134.38230.92283.07248.84146.41
Gain (Loss) on Sale of Investments
-2.79-0.495.5-4.494.9511.66
Gain (Loss) on Sale of Assets
------0.52
Asset Writedown
-2.07-1.48-0.15-0.37-1.58-
Other Unusual Items
11.625.53.9312.553.661.84
Pretax Income
-23.51137.9240.2290.76255.86159.39
Income Tax Expense
-18.987.3333.4136.8620.4813.46
Net Income
-4.53130.57206.79253.9235.38145.93
Net Income to Common
-4.53130.57206.79253.9235.38145.93
Net Income Growth
--36.86%-18.55%7.87%61.29%68.05%
Shares Outstanding (Basic)
794816827819804794
Shares Outstanding (Diluted)
794816827819804794
Shares Change
-4.85%-1.34%0.99%1.92%1.16%6.67%
EPS (Basic)
-0.010.160.250.310.290.18
EPS (Diluted)
-0.010.160.250.310.290.18
EPS Growth
--36.00%-19.36%5.84%59.45%57.55%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-31.252.0666.6258.38-151.35-136.95
Free Cash Flow Per Share
-0.040.060.080.07-0.19-0.17
Dividend Per Share
0.0640.0640.1000.0920.0570.037
Dividend Growth
-36.00%-36.00%8.58%61.30%53.91%62.72%
Gross Margin
45.42%51.04%53.05%54.40%51.27%54.14%
Operating Margin
-0.33%14.79%23.20%29.94%26.84%26.72%
Profit Margin
-0.60%16.47%26.00%31.09%30.79%25.61%
Free Cash Flow Margin
-4.12%6.57%8.38%7.15%-19.80%-24.04%
EBITDA
77.28190.06248.13285.14239.68182.22
EBITDA Margin
10.21%23.97%31.20%34.91%31.35%31.99%
D&A For EBITDA
79.7672.8663.6640.5934.4830.02
EBIT
-2.47117.21184.48244.54205.2152.2
EBIT Margin
-0.33%14.79%23.20%29.94%26.84%26.71%
Effective Tax Rate
-5.32%13.91%12.68%8.01%8.45%
Revenue as Reported
757.05792.76795.29816.77764.55569.7